Zobrazeno 1 - 10
of 605
pro vyhledávání: '"PLA2R"'
Autor:
Xiaodan Li, Dongxu Song, Yingxuan Hao, Mingjing Ren, Yanhong Guo, Huayan Zhao, Yulin Wang, Lin Tang
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Rituximab occasionally induces reactivation of hepatitis C virus (HCV) in patients with resolved HCV infection, sometimes with fatal consequences. As rituximab has become one of the first-line therapies for the treatment of phospholipase A2
Externí odkaz:
https://doaj.org/article/0615567a036641ae8f2678217085630f
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundParticulate matter (PM2.5) has been implicated in the development of membranous nephropathy (MN), but the underlying mechanism has yet to be fully understood. Oxidative stress is an essential factor of PM2.5-related toxicity and plays a sig
Externí odkaz:
https://doaj.org/article/b92dfb402d4f42e3addd2c548c040ed4
Publikováno v:
ImmunoTargets and Therapy, Vol Volume 13, Pp 385-398 (2024)
Yan Pan, Wei Dong Chen, Lei Liu, Huijuan Yang, Baochao Chang, Caixia Cui Department of Nephrology, First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui Province, People’s Republic of ChinaCorrespondence: Wei Dong Chen, Email cwd2012@1
Externí odkaz:
https://doaj.org/article/f58a964ea0f0475aae4b79e751b84897
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-8 (2024)
Abstract Background Sarcoidosis is a multisystemic inflammatory disease, characterized by the presence of non-caseating, epithelioid granulomas. Glomerular disease in patients with sarcoidosis is rare and membranous nephropathy (MN) is cited as the m
Externí odkaz:
https://doaj.org/article/f3ff431f0caa4c86a1db9b2f60470312
Publikováno v:
Cancer Management and Research, Vol Volume 16, Pp 677-689 (2024)
Guoqin Wang,1,* Xiaoying Hu,1,* Nan Ye,1 Xiaoyi Xu,1 Weiyi Guo,1 Lijun Sun,1 Hongrui Dong,1 Xiaoyi Zhao,2 Hong Cheng1 1Division of Nephrology, Beijing Anzhen Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Divisi
Externí odkaz:
https://doaj.org/article/5738dfd1e1484b61af79deab2c5da893
Autor:
Hou, Shulin a, b, ⁎, 1, He, Huili b, 1, Yang, Haishan c, Chen, Chunrong b, Wang, Qian b, Wu, Zhifang a, Li, Sijin a, ⁎⁎, Xie, Jun b, ⁎⁎⁎
Publikováno v:
In Biochemical and Biophysical Research Communications January 2025 742
Publikováno v:
MedComm, Vol 5, Iss 7, Pp n/a-n/a (2024)
Abstract Membranous nephropathy (MN), an autoimmune disease, can manifest at any age and is among the most common causes of nephrotic syndrome in adults. In 80% of cases, the specific etiology of MN remains unknown, while the remaining cases are link
Externí odkaz:
https://doaj.org/article/21d140edf08a42e097045d354cb2920b
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-7 (2023)
Abstract Background Membranous nephropathy (MN) is a major pattern of nephrotic syndrome (NS) in adults. Some MN have secondary causes and some may be accompanied with other glomerular diseases. MN patients coexisting with amyloidosis are very rare,
Externí odkaz:
https://doaj.org/article/812b1550c2b24a5c97e63bc37049aa0e
Autor:
Patimat A. Kakhsurueva, Elena S. Kamyshova, Irina N. Bobkova, Ekaterina V. Stavrovskaya, Tatiana E. Rudenko, Elena Y. Andreeva
Publikováno v:
Терапевтический архив, Vol 95, Iss 6, Pp 462-467 (2023)
Background. Membranous nephropathy (MN) is an immunocomplex glomerular disease, which is the most common cause of nephrotic syndrome in adults. Numerous studies have established that autoantibodies against the target podocyte autoantigens, including
Externí odkaz:
https://doaj.org/article/584e37cb940b465ba9bf56f8e8724a8e
Autor:
Dóra Bajcsi, László Bitó, Sándor Turkevi-Nagy, Tibor Nyári, Éva Kemény, Péter Légrády, György Ábrahám, Béla Iványi
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-11 (2023)
Abstract Background The diagnostic performance of PLA2R and IgG subclass staining of kidney biopsies relative to anti-PLA2R seropositivity in the differentiation of primary and secondary membranous nephropathy (pMN, sMN) was examined. Besides PLA2R s
Externí odkaz:
https://doaj.org/article/c953647d1efb4ec6802e5feadfe37d88